Endometriosis Treatment Market Research Report to 2025 - Cumulative Impact of COVID-19

by Drug Type (GnRH Analogues, LNR-IUDS, NSAIDs, Oral Contraceptives, and Progestins), by Treatment Type (Hormonal Therapy and Pain Management), by Distribution Channel

Published	Pages	Publisher	Report code
Aug 2020	229	360 iResearch	ASDR-548132

Published: Aug 2020 - Pages : 229 - Publisher : 360 iResearch - Report code : ASDR-548132

AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca Plc.
Bayer AG
Eli Lilly and Company
Meditrina Pharmaceuticals Private Limited
Neurocrine Biosciences Inc.
Pfizer Inc.
Takeda Pharmaceutical Company

Print page | Download Sample pages

Endometriosis Treatment Market United States Forecast to 2025 - Cumulative Impact of COVID-19

This report can be of interest as well:

Endometriosis Treatment Market United States Forecast to 2025 - Cumulative Impact of COVID-19

Published: August, 2020 | Report code: ASDR-551675

Mark your calendar:

National Congress on Military and Veterans Healthcare Systems

17 October - 19 October, 2023
Arlington, United States